Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

The sustainability of public health interventions in schools: a systematic review.

Herlitz L, MacIntyre H, Osborn T, Bonell C.

Implement Sci. 2020 Jan 6;15(1):4. doi: 10.1186/s13012-019-0961-8. Review.

2.

Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/lpr lupus mice.

Huang MW, Stock AD, Mike EV, Herlitz L, Kolbeck R, Putterman C.

Lupus. 2019 Nov;28(13):1510-1523. doi: 10.1177/0961203319872265. Epub 2019 Aug 31. Erratum in: Lupus. 2019 Nov;28(13):1615.

PMID:
31474191
3.

Immune Check Point Inhibitor-Associated Glomerulonephritis.

Ashour T, Nakhoul G, Patil P, Funchain P, Herlitz L.

Kidney Int Rep. 2018 Oct 29;4(2):355-359. doi: 10.1016/j.ekir.2018.10.017. eCollection 2019 Feb. No abstract available.

4.

NF-kB signaling in myeloid cells mediates the pathogenesis of immune-mediated nephritis.

Chalmers SA, Garcia SJ, Reynolds JA, Herlitz L, Putterman C.

J Autoimmun. 2019 Mar;98:33-43. doi: 10.1016/j.jaut.2018.11.004. Epub 2019 Jan 3.

5.

BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.

Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.

Clin Immunol. 2018 Dec;197:205-218. doi: 10.1016/j.clim.2018.10.008. Epub 2018 Oct 16.

6.

"Atrophic Kidney"-like Lesion: Clinicopathologic Series of 8 Cases Supporting a Benign Entity Distinct From Thyroid-like Follicular Carcinoma.

Herlitz L, Hes O, Michal M, Tretiakova M, Reyes-Múgica M, Nguyen JK, Troxell ML, Przybycin CG, Magi-Galluzzi C, McKenney JK.

Am J Surg Pathol. 2018 Dec;42(12):1585-1595. doi: 10.1097/PAS.0000000000001157.

PMID:
30285996
7.

Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.

Mike EV, Makinde HM, Gulinello M, Vanarsa K, Herlitz L, Gadhvi G, Winter DR, Mohan C, Hanly JG, Mok CC, Cuda CM, Putterman C.

J Autoimmun. 2019 Jan;96:59-73. doi: 10.1016/j.jaut.2018.08.005. Epub 2018 Aug 30.

8.

A 22-Year-Old Woman With Systemic Lupus Erythematosus Presents With Two Damaged Kidneys, One Seizure, No Platelets, and Many Possible Diagnoses.

Zickuhr L, Herlitz LC, Chatterjee S.

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1686-1693. doi: 10.1002/acr.23561. No abstract available.

9.

C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.

Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB.

Kidney Int. 2018 Apr;93(4):977-985. doi: 10.1016/j.kint.2017.10.022. Epub 2018 Jan 6.

PMID:
29310824
10.

Autosomal Dominant Tubulointerstitial Kidney Disease Due to MUC1 Mutation.

Yu SM, Bleyer AJ, Anis K, Herlitz L, Živná M, Hůlková H, Markowitz GS, Jim B.

Am J Kidney Dis. 2018 Apr;71(4):495-500. doi: 10.1053/j.ajkd.2017.08.024. Epub 2017 Dec 6.

PMID:
29217307
11.

Randomized controlled trial of Functional Family Therapy for offending and antisocial behavior in UK youth.

Humayun S, Herlitz L, Chesnokov M, Doolan M, Landau S, Scott S.

J Child Psychol Psychiatry. 2017 Sep;58(9):1023-1032. doi: 10.1111/jcpp.12743. Epub 2017 May 15.

12.

Tubulointerstitial Injury and Drugs of Abuse.

Nanavati A, Herlitz LC.

Adv Chronic Kidney Dis. 2017 Mar;24(2):80-85. doi: 10.1053/j.ackd.2016.09.008. Review.

PMID:
28284383
13.

A 31-Year-Old Man With a Ring-Enhancing Brain Lesion.

Riley CS, Roth LA, Sampson JB, Radhakrishnan J, Herlitz LC, Blitz AM, Moazami G.

J Neuroophthalmol. 2017 Jun;37(2):172-175. doi: 10.1097/WNO.0000000000000469. No abstract available.

PMID:
28079760
14.

Spinal cord hemangioblastomas: significance of intraoperative neurophysiological monitoring for resection and long-term outcome.

Siller S, Szelényi A, Herlitz L, Tonn JC, Zausinger S.

J Neurosurg Spine. 2017 Apr;26(4):483-493. doi: 10.3171/2016.8.SPINE16595. Epub 2016 Dec 16.

PMID:
27982764
15.

CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.

Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.

Clin Immunol. 2017 Dec;185:100-108. doi: 10.1016/j.clim.2016.08.019. Epub 2016 Aug 26.

16.

Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Motwani SS, Herlitz L, Monga D, Jhaveri KD, Lam AQ; American Society of Nephrology Onco-Nephrology Forum.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2260-2272. Epub 2016 Aug 15. Review.

17.

Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine Kinase.

Chalmers SA, Doerner J, Bosanac T, Khalil S, Smith D, Harcken C, Dimock J, Der E, Herlitz L, Webb D, Seccareccia E, Feng D, Fine JS, Ramanujam M, Klein E, Putterman C.

Sci Rep. 2016 May 19;6:26164. doi: 10.1038/srep26164.

18.

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.

Stock AD, Wen J, Doerner J, Herlitz LC, Gulinello M, Putterman C.

J Neuroinflammation. 2015 Nov 6;12:205. doi: 10.1186/s12974-015-0423-4.

19.

Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era.

Stokes MB, Valeri AM, Herlitz L, Khan AM, Siegel DS, Markowitz GS, D'Agati VD.

J Am Soc Nephrol. 2016 May;27(5):1555-65. doi: 10.1681/ASN.2015020185. Epub 2015 Sep 15.

20.

Predictors of outcome for severe IgA Nephropathy in a multi-ethnic U.S. cohort.

Arroyo AH, Bomback AS, Butler B, Radhakrishnan J, Herlitz L, Stokes MB, D'Agati V, Markowitz GS, Appel GB, Canetta PA.

Clin Nephrol. 2015 Sep;84(3):145-55. doi: 10.5414/CN108556.

PMID:
26226949
21.

Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.

Chan ES, Herlitz LC, Ali J.

J Invest Dermatol. 2015 Sep;135(9):2338-2339. doi: 10.1038/jid.2015.216. Epub 2015 Jul 2. No abstract available.

22.

Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.

Chan ES, Herlitz LC, Jabbari A.

J Invest Dermatol. 2015 Jul;135(7):1912-1915. doi: 10.1038/jid.2015.107. Epub 2015 Mar 19. No abstract available. Erratum in: J Invest Dermatol. 2015 Sep;135(9):2338-9.

23.

Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.

Sise ME, Hirsch JS, Canetta PA, Herlitz L, Mohan S.

AIDS. 2015 May 15;29(8):941-6. doi: 10.1097/QAD.0000000000000628.

PMID:
25784440
24.

Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.

Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C.

J Autoimmun. 2015 Feb;57:42-52. doi: 10.1016/j.jaut.2014.11.007. Epub 2014 Dec 29.

25.

Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Xia Y, Herlitz LC, Gindea S, Wen J, Pawar RD, Misharin A, Perlman H, Wu L, Wu P, Michaelson JS, Burkly LC, Putterman C.

J Am Soc Nephrol. 2015 May;26(5):1053-70. doi: 10.1681/ASN.2014030233. Epub 2014 Sep 30.

26.

B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis.

Pawar RD, Goilav B, Xia Y, Herlitz L, Doerner J, Chalmers S, Ghosh K, Zang X, Putterman C.

Clin Exp Immunol. 2015 Feb;179(2):329-43. doi: 10.1111/cei.12452.

27.

Renal Infections.

Hou J, Herlitz LC.

Surg Pathol Clin. 2014 Sep;7(3):389-408. doi: 10.1016/j.path.2014.04.004. Epub 2014 Jun 26. Review.

PMID:
26837446
28.

Nephrotoxic effects of common and emerging drugs of abuse.

Pendergraft WF 3rd, Herlitz LC, Thornley-Brown D, Rosner M, Niles JL.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1996-2005. doi: 10.2215/CJN.00360114. Epub 2014 Jul 17. Review. Erratum in: Clin J Am Soc Nephrol. 2019 Apr 5;14(4):586.

29.

Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin.

Pawar RD, Goilav B, Xia Y, Zhuang H, Herlitz L, Reeves WH, Putterman C.

Clin Immunol. 2014 Sep;154(1):49-65. doi: 10.1016/j.clim.2014.06.007. Epub 2014 Jun 24.

30.

Rituximab treatment for fibrillary glomerulonephritis.

Hogan J, Restivo M, Canetta PA, Herlitz LC, Radhakrishnan J, Appel GB, Bomback AS.

Nephrol Dial Transplant. 2014 Oct;29(10):1925-31. doi: 10.1093/ndt/gfu189. Epub 2014 May 27.

PMID:
24867652
31.

IgA nephropathy with minimal change disease.

Herlitz LC, Bomback AS, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1033-9. doi: 10.2215/CJN.11951113. Epub 2014 Apr 10.

32.

De novo membranous nephropathy in renal allograft associated with antibody-mediated rejection and review of the literature.

Patel K, Hirsch J, Beck L, Herlitz L, Radhakrishnan J.

Transplant Proc. 2013 Nov;45(9):3424-8. doi: 10.1016/j.transproceed.2013.05.011. Review.

PMID:
24182829
33.

Toward a working definition of C3 glomerulopathy by immunofluorescence.

Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD.

Kidney Int. 2014 Feb;85(2):450-6. doi: 10.1038/ki.2013.340. Epub 2013 Sep 25.

34.

The modern spectrum of renal biopsy findings in patients with diabetes.

Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS, D'Agati VD.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1718-24. doi: 10.2215/CJN.02510213. Epub 2013 Jul 25.

35.

The changing pattern of glomerular disease in HIV and hepatitis C co-infected patients in the era of HAART.

Mohan S, Herlitz LC, Tan J, Cheng JT, Anderson HL, Stokes MB, Markowitz GS, D'Agati VD, Radhakrishnan J.

Clin Nephrol. 2013 Apr;79(4):285-91. doi: 10.5414/CN107774.

PMID:
23320974
36.

BK polyoma virus nephropathy in the native kidney.

Sharma SG, Nickeleit V, Herlitz LC, de Gonzalez AK, Stokes MB, Singh HK, Markowitz GS, D'Agati VD.

Nephrol Dial Transplant. 2013 Mar;28(3):620-31. doi: 10.1093/ndt/gfs537. Epub 2012 Dec 18.

PMID:
23249622
37.

Renal cortical infarction following treatment with sumatriptan in a kidney allograft recipient.

Sharma SG, Post JB, Herlitz LC, Markowitz G.

Am J Kidney Dis. 2013 Feb;61(2):326-9. doi: 10.1053/j.ajkd.2012.07.032. Epub 2012 Dec 1.

PMID:
23206532
38.

Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

Xia Y, Campbell SR, Broder A, Herlitz L, Abadi M, Wu P, Michaelson JS, Burkly LC, Putterman C.

Clin Immunol. 2012 Nov;145(2):108-21. doi: 10.1016/j.clim.2012.08.008. Epub 2012 Aug 20.

39.

The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies.

Xia Y, Pawar RD, Nakouzi AS, Herlitz L, Broder A, Liu K, Goilav B, Fan M, Wang L, Li QZ, Casadevall A, Putterman C.

J Autoimmun. 2012 Dec;39(4):398-411. doi: 10.1016/j.jaut.2012.06.005. Epub 2012 Jul 28.

40.

Crystalline nephropathies.

Herlitz LC, D'Agati VD, Markowitz GS.

Arch Pathol Lab Med. 2012 Jul;136(7):713-20. doi: 10.5858/arpa.2011-0565-RA. Review.

PMID:
22742545
41.

Pathology after eculizumab in dense deposit disease and C3 GN.

Herlitz LC, Bomback AS, Markowitz GS, Stokes MB, Smith RN, Colvin RB, Appel GB, D'Agati VD.

J Am Soc Nephrol. 2012 Jul;23(7):1229-37. doi: 10.1681/ASN.2011121186. Epub 2012 Jun 7.

42.

Renal biopsy in the elderly and very elderly: useful or not?

Bomback AS, Herlitz LC, Markowitz GS.

Adv Chronic Kidney Dis. 2012 Mar;19(2):61-7. doi: 10.1053/j.ackd.2011.09.003. Review.

PMID:
22449342
43.

Eculizumab for dense deposit disease and C3 glomerulonephritis.

Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D'Agati VD, Canetta PA, Radhakrishnan J, Appel GB.

Clin J Am Soc Nephrol. 2012 May;7(5):748-56. doi: 10.2215/CJN.12901211. Epub 2012 Mar 8.

44.

Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.

Pawar RD, Pitashny M, Gindea S, Tieng AT, Levine B, Goilav B, Campbell SR, Xia Y, Qing X, Thomas DB, Herlitz L, Berger T, Mak TW, Putterman C.

Arthritis Rheum. 2012 May;64(5):1620-31. doi: 10.1002/art.33485.

45.

The big squeeze: giant cells in granulomatous interstitial nephritis.

Herlitz LC, Zdunek MP, D'Agati VD, Markowitz GS.

Kidney Int. 2011 Aug;80(4):434. doi: 10.1038/ki.2011.187. No abstract available.

46.

ANCA-associated glomerulonephritis in the very elderly.

Bomback AS, Appel GB, Radhakrishnan J, Shirazian S, Herlitz LC, Stokes B, D'Agati VD, Markowitz GS.

Kidney Int. 2011 Apr;79(7):757-64. doi: 10.1038/ki.2010.489. Epub 2010 Dec 15.

47.

Acute kidney injury in the setting of AIDS, bland urine sediment, minimal proteinuria and normal-sized kidneys: a presentation of renal lymphoma.

Sandhu G, Ranade A, Mankal P, Herlitz LC, Jones J, Cortell S.

Nephrol Dial Transplant. 2011 Feb;26(2):747-51. doi: 10.1093/ndt/gfq666. Epub 2010 Nov 4.

PMID:
21051499
48.

Validation and implementation of an algorithm for reporting the automated absolute neutrophil count from selected flagged specimens.

Sireci AN, Herlitz L, Lee K, Bautista JL, Kratz A.

Am J Clin Pathol. 2010 Nov;134(5):720-5. doi: 10.1309/AJCP9PEDYQMFGMA3.

PMID:
20959654
49.

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS.

Kidney Int. 2010 Dec;78(11):1171-7. doi: 10.1038/ki.2010.318. Epub 2010 Sep 1.

50.

The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity.

Agarwala R, Mohan S, Herlitz LC, Cheng JT.

Kidney Int. 2010 Mar;77(5):475-6. doi: 10.1038/ki.2009.486. No abstract available.

Supplemental Content

Loading ...
Support Center